BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 17195964)

  • 1. The impact of renal insufficiency on patients' outcomes in emergent angioplasty for acute myocardial infarction.
    Assali AR; Brosh D; Ben-Dor I; Solodky A; Fuchs S; Teplitsky I; Kornowski R
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):395-400. PubMed ID: 17195964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Rasoul S; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Marcel Gosselink AT; Zijlstra F; Suryapranata H; van 't Hof AW;
    Coron Artery Dis; 2009 Sep; 20(6):415-21. PubMed ID: 19641460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of percutaneous coronary interventions in patients > or =90 years of age.
    Teplitsky I; Assali A; Lev E; Brosh D; Vaknin-Assa H; Kornowski R
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):937-43. PubMed ID: 17621664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry.
    Bae EH; Lim SY; Cho KH; Choi JS; Kim CS; Park JW; Ma SK; Jeong MH; Kim SW
    Am J Kidney Dis; 2012 Jun; 59(6):795-802. PubMed ID: 22445708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty.
    Yip HK; Wu CJ; Chang HW; Yang CH; Yu TH; Chen YH; Hang CL
    Chest; 2005 May; 127(5):1491-7. PubMed ID: 15888819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
    Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
    Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
    Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
    J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
    Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of glomerular filtration rate with unsuccessful primary percutaneous coronary intervention and subsequent mortality in patients with acute myocardial infarction: from the HIJAMI registry.
    Koganei H; Kasanuki H; Ogawa H; Tsurumi Y
    Circ J; 2008 Feb; 72(2):179-85. PubMed ID: 18219150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
    De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
    Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
    Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty.
    Beeres SL; Oemrawsingh PV; Warda HM; Bechan R; Atsma DE; Jukema JW; van der Wall EE; Schalij MJ
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):478-83. PubMed ID: 15973655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.
    Brosh D; Assali AR; Mager A; Porter A; Hasdai D; Teplitsky I; Rechavia E; Fuchs S; Battler A; Kornowski R
    Am J Cardiol; 2007 Feb; 99(4):442-5. PubMed ID: 17293180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcome of coronary artery aneurysm in patients with acute myocardial infarction undergoing a primary percutaneous coronary intervention.
    Yip HK; Chen MC; Wu CJ; Hang CL; Hsieh KY; Fang CY; Yeh KH; Fu M
    Cardiology; 2002; 98(3):132-40. PubMed ID: 12417812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary angioplasty for acute myocardial infarction--the emerging prognostic role of renal insufficiency.
    Bartorelli AL
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):401-2. PubMed ID: 17295289
    [No Abstract]   [Full Text] [Related]  

  • 20. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.